相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In vitro effects of the CCR5 inhibitor maraviroc on human T cell function
H. Arberas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex
Qiuxiang Tan et al.
SCIENCE (2013)
T-cell changes after a short-term exposure to maraviroc in HIV-infected patients are related to antiviral activity
Ildefonso Pulido et al.
JOURNAL OF INFECTION (2012)
Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease
Ran Reshef et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Clinical studies with chemokine receptor-5 (CCR5)-inhibitors
Christoph Boesecke et al.
CURRENT OPINION IN HIV AND AIDS (2012)
Human regulatory T cells in allogeneic stem cell transplantation
Sya N. Ukena et al.
BLOOD (2011)
In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells
R. Rossi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
The effect of the CCR5-delta32 deletion on global gene expression considering immune response and inflammation
Gero Huetter et al.
JOURNAL OF INFLAMMATION-LONDON (2011)
Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages
Cecilia Lasser et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Chemokines and Their Receptors in Human Renal Allotransplantation
Denise J. Lo et al.
TRANSPLANTATION (2011)
Chemokine Receptor CCR5 Mediates AlloImmune Responses in Graft-versus-Host Disease
Lisa A. Palmer et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
The role of chemokine receptors in acute lung allograft rejection
S. Geleff et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Effects of Maraviroc and Efavirenz on Markers of Immune Activation and Inflammation and Associations with CD4+ Cell Rises in HIV-Infected Patients
Nicholas Funderburg et al.
PLOS ONE (2010)
Modulation of chemokine receptor activity through dimerization and crosstalk
C. L. Salanga et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
The biology of CCR5 and CXCR4
Ghalib Alkhatib
CURRENT OPINION IN HIV AND AIDS (2009)
Maraviroc for previously treated patients with R5 HIV-1 infection
Roy M. Gulick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantation
Sung W. Choi et al.
BLOOD (2007)
Chemokine-mediated inflammation: Identification of a possible regulatory role for CCR2
Graeme O'Boyle et al.
MOLECULAR IMMUNOLOGY (2007)
Biology of CCR5 and its role in HIV infection and treatment
Michael M. Lederman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers
L El-Asmar et al.
MOLECULAR PHARMACOLOGY (2005)
Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning
CA Wysocki et al.
JOURNAL OF IMMUNOLOGY (2004)
Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction
M Murai et al.
NATURE IMMUNOLOGY (2003)
分享论文
